Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperdal Effect on Frontal Metabolism in Asperger's Disorder
NCT00352196Phase 4Completed
- Sponsor
- Augusta University
- Start
- Nov 2001
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in Autism Spectrum Disorder (ASD), sponsored by Augusta University. Started Nov 2001; status: completed.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00352196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352196.